CIK 0001830487
- Large accelerated filer
Pharvaris N.V.
Sign in to watch- Ticker
- PHVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- Other
- Phone
- +31 712036410
- Business address
- J.H. OORTWEG 21, 2333 CH LEIDEN, LEIDEN, Netherlands
- Former names
- Pharvaris, B.V.
- 4 Planned sale Chief Executive Officer sold 2,292 shares at $34.77 ($79,686)
- 4 Shares withheld for taxes President gave up 226 shares (to pay taxes)
- 4 Planned sale Chief Executive Officer sold 2,292 shares at $34.97 ($80,154)
- 4 Shares withheld for taxes Chief Medical Officer gave up 226 shares (to pay taxes)
- 4 Planned sale Director sold 37,600 shares at an average $35.41 ($1,331,496)
- 4 Planned sale Chief Early Development sold 76,172 shares at an average $35.39 ($2,695,452)
- 4 Planned sale Chief Early Development sold 4,600 shares at an average $35.12 ($161,560)
- 4 Planned sale Director sold 2,400 shares at $35.10 ($84,250)
- 4 Planned sale Chief Medical Officer sold 29,700 shares at an average $34.30 ($1,018,832)
- 4 Planned sale Chief Medical Officer sold 300 shares at $34.00 ($10,200)
- 4 Planned sale Chief Executive Officer sold 2,291 shares at an average $31.07 ($71,173)
- 4 Shares withheld for taxes Chief Medical Officer gave up 117 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 109 shares (to pay taxes)
- 4 Open-market sale Principal Accounting Officer sold 2,670 shares at $30.87 ($82,425)
- 4 Open-market sale Director sold 9,667 shares at $30.29 ($292,853)
- 4 Open-market sale Principal Accounting Officer sold 7,330 shares at an average $30.70 ($225,055)
- 4 Open-market sale CFO / CLO sold 10,000 shares at $30.31 ($303,076)
- 4 Planned sale Director sold 10,000 shares at $29.32 ($293,166)
- 4/A Insider Changes in Ownership
- 4 Planned sale Chief Executive Officer sold 2,292 shares at $29.22 ($66,977)
Page 2 of 4 · 71 filings